Products
Online Inquiry

Please note that we are not a pharmacy or clinic, so we are unable to see patients and do not offer diagnostic and treatment services for individuals.

Vitamin B12 test kit

S3I-201

Cat. No.: OB0225WX-2397
Appearance: Solid
Purity: ≥99%
Identity: Confirmed by NMR, and HPLC.
Size:
S3I-201
Add to basket

Product Overview

Description: S3I-201 is a potent inhibitor of STAT3 DNA-binding activity (IC50: 86 microM) characterized by its low cross-reactivity with STAT1 and STAT5.
Synonym: NSC 74859; 501919-59-1; Nsc 74859; 2-hydroxy-4-(2-(tosyloxy)acetamido)benzoic acid; S31-201; 2-Hydroxy-4-[[2-[[(4-methylphenyl)sulfonyl]oxy]acetyl]amino]benzoic acid; Benzoic acid, 2-hydroxy-4-((2-(((4-methylphenyl)sulfonyl)oxy)acetyl)amino)-; 2-hydroxy-4-{2-[(4-methylbenzenesulfonyl)oxy]acetamido}benzoic acid; S2I-201; Stat3 Inhibitor VI, S3I-201; 2-Hydroxy-4-[[2-(4-methylphenyl)sulfonyloxyacetyl]amino]benzoic acid; 2-Hydroxy-4-((((4-methylphenyl)sulfonyloxy)acetyl)amino)-benzoic acid; 2-Hydroxy-4-(((4-methylphenyl)sulfonyloxy)acetyl)amino)-benzoic acid; 2-Hydroxy-4-(2-{[(4-methylbenzene)sulfonyl]oxy}acetamido)benzoic acid; 2-hydroxy-4-{2-[(4-methylbenzene-1-sulfonyl)oxy]acetamido}benzoic acid
CAS No.: 501919-59-1
Compound CID: 252682
Formula: C16H15NO7S
Formula Weight: 365.36

Specification

Stability: 3 years in powder form.
Storage: Storage at -20°C.
Applications: S3I-201 is utilized in signal transduction research as a selective STAT3 inhibitor to study the disruption of STAT3 dimerization and the subsequent inhibition of STAT3-dependent gene transcription in cancer cells.

Library Information

Target: STAT
Receptor: STAT3
Pathways: JAK/STAT
Plate Number: L6700-01
Empty Location: a1-h1; a12-h12
Container: 96-well plate
Formulation: 10mM DMSO
DMSO Max Solubility: 73 mg/mL; 199.8 mM
ALogP: 1.712
HBA_Count: 3
HBD_Count: 2
Rotatable Bond: 6
Inquiry
0
Inquiry Basket

Copyright © Protheragen. All rights reserves.